The cost effectiveness of combination antiretroviral therapy for HIV disease

Article Abstract:

Combination antiretroviral therapy for HIV infection is cost-effective, according to a mathematical simulation. Although the lifetime costs of treatment per patient increased from $45,460 to $77,300, life expectancy also increased. Consequently, the cost per quality-adjusted year of life gained was between $13,000 and $23,000.

Anti-HIV agents

---

Expanded screening for HIV in the United States - an analysis of cost-effective

Article Abstract:

A computer simulation model of Human immune-deficiency virus (HIV) screening and treatment to compare routine, voluntary HIV counseling, testing, and referrals (HIVCTR) with recent practice in 'high-risk', 'CDC threshold' and 'US general' is developed. In all but lowest-risk populations, routine, voluntary screening for HIV once every three to five years is justified on both clinical and cost-effectiveness grounds.

United Kingdom, United States, Care and treatment, Diagnosis

---

Cost-effectiveness of HIV treatment in resource-poor settings -- the case of Cote d'Ivoire

Article Abstract:

The cost-effectiveness of different treatment strategies for adults infected with human immunodeficiency virus (HIV) in Cote d'Ivoire, a setting with limited resources, is assessed. Studies suggest that a strategy of trimethoprim-sulfamethoxazole prophylaxis and antiretroviral therapy, with the use of clinical criteria alone or combined with CD4 testing, is the most cost-effective treatment for HIV in settings with limited resources.

New England States, Dosage and administration, AIDS treatment, Trimethoprim

Similar abstracts:

• Abstracts: Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. Do Statins Prevent Both Cardiovascular Disease and Fracture?
• Abstracts: Cost-effectiveness of urodynamic testing before surgery for women with pelvic organ prolapse and stress urinary incontinence
• Abstracts: Zidovudine and stavudine sequencing in IHV treatment planning: findings from the CHORUS HIV cohort. Effect of persistent moderate viremia on disease progression during HIV therapy
• Abstracts: The effects of ibuprofen on the physiology and survival of patients with sepsis. Efficacy and safety of recombinant human activated protein C for severe sepsis
• Abstracts: Predicting outcomes of trials of labor in women attempting vaginal birth after cesarean delivery: a comparison of multivariate methods with neural networks

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.